NRD
USPH icon

Nebula Research & Development’s US Physical Therapy USPH Stock Holding History

Nebula Research & Development’s Portfolio USPH Stock Details USPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,333
Closed -$828K – 1152
2024
Q4 		$828K Sell
9,333
-446
-5% -$39.7K 0.1% 352
2024
Q3 		$828K Buy
+9,779
New +$868K 0.1% 380

Other funds holding USPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nebula Research & Development's USPH Position: Q1 2025 in Review

Nebula Research & Development sold out of US Physical Therapy (USPH) in Q1 2025, closing a stake of 9,333 shares — an estimated $828K sold.

Nebula Research & Development first reported a position in USPH in Q3 2024 and held it in 2 quarters. The position peaked at $828K in Q4 2024. 253 funds tracked by Wall St. Rank hold USPH as of Q1 2025.

  • Nebula Research & Development reported no remaining US Physical Therapy position as of Q1 2025 after selling out during the quarter.
  • Nebula Research & Development sold 9,333 US Physical Therapy shares in Q1 2025, an estimated $828K.
  • Nebula Research & Development first reported a position in US Physical Therapy in Q3 2024 and held it in 2 quarters.
  • Nebula Research & Development's US Physical Therapy position peaked at $828K in Q4 2024.
  • 253 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2025.

Based on Nebula Research & Development's 13F filing for Q1 2025, filed 15 May 2025.